It was discovered that SIRT1 knockdown in human breast cancer cells resulted in a decrease in hTERT mRNA expression at the third day and enzyme activity at the fifth day of treatment as evidenced by RT-PCR and TRAP activity, respectively. This evidence concerns the gene SIRT1 and breast cancer.